Clinical Trials Browser

Terminated × Triptorelin Pamoate × Genitourinary × Clear all

NCT01673984 2025-05-23

GREAT

Phase 4 Terminated

27 enrolled 13 charts

Prostatic Neoplasms

NCT02168062 2020-07-23

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

Phase 2 Terminated

57 enrolled 27 charts

Prostate Adenocarcinoma

NCT00415246 2019-11-22

Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00444639 2019-11-22

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

Phase 2 Terminated

Prostatic Neoplasms

NCT01374087 2019-09-18

ANABRAQ

Phase 2 Terminated

32 enrolled 9 charts

Prostatic Neoplasms

NCT02749825 2016-04-25

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Phase 4 Terminated

Neoplasms, Prostatic Neoplasms